US2012270202A1PendingUtilityA1

Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity

Individually held — no corporate assignee on recordPriority: Jan 25, 2000Filed: Oct 17, 2011Published: Oct 25, 2012
Est. expiryJan 25, 2020(expired)· nominal 20-yr term from priority
A61P 37/02C07K 16/18A61K 39/001A61K 2039/515A61K 38/1709A61K 38/168A61P 37/06A61K 35/34A61K 2039/505A61K 40/418A61K 40/24A61K 40/22A61K 40/13
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention includes the composition of organ grafts accommodated prior to transplantation and therefore resistant to rejection by preformed antibodies. Accommodation is achieved within the donor animal by administration of sub-lethal levels of accommodation inducing factors derived from animals sensitized to the donor.

Claims

exact text as granted — not AI-modified
1 . A xenograft from a donor mammal prepared by a method comprising:
 (i) infusing a non-human pre-immune fetal donor mammal at least one time with sub-lethal levels of bone marrow,   (ii) allowing prolonged exposure of the donor mammal to the bone marrow,   (iii) harvesting a xenograft from the donor mammal; and   (iv) determining that the xenograft from the donor mammal is resistant to complement-dependent cytotoxicity mediated by preformed antibodies of a sensitized recipient mammal reactive with donor antigen,   
       wherein the xenograft is a tissue or an organ. 
     
     
         2 . The xenograft of  claim 1 , wherein the bone marrow is from a mammal which is of the same species as the sensitized recipient. 
     
     
         3 . The xenograft of  claim 1 , wherein the sensitized recipient mammal is a human. 
     
     
         4 . The xenograft of  claim 1 , wherein the bone marrow is from the sensitized recipient mammal. 
     
     
         5 . The xenograft of  claim 1 , wherein the xenograft is an organ and the organ is selected from the group consisting of heart, kidney, liver, lung, pancreas, intestine, spleen, and thymus. 
     
     
         6 . The xenograft of  claim 1 , wherein the xenograft is a tissue and the tissue is selected from the group consisting of bone, skin, neural tissue, skeletal muscle myocytes, smooth muscle myocytes, cardiac muscle myocytes, pancreatic islets, hepatocytes, stem cells, progenitor cells, and hematopoietic cells. 
     
     
         7 . The xenograft of  claim 1 , wherein the step of determining occurs prior to the step of harvesting.

Join the waitlist — get patent alerts

Track US2012270202A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.